Glivec® (Imatinib Mesylate, STI571) in Monotherapy Versus Glivec®-Interferon Alpha in the Treatment of Chronic-Phase Chronic Myeloid Leukaemia
Clinical trial NCT00390897 · COMPLETED
Trial details
- NCT number
- NCT00390897
- Sponsor
- PETHEMA Foundation
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2003-07-01
- Primary completion
- 2006-10-01
- Enrollment
- 360
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.